title: Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome.
authors.forename: Takamasa
authors.initials: T
authors.lastname: Nishiuchi
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Okutani
authors.forename: Toshikazu
authors.initials: T
authors.lastname: Fujita
authors.forename: Kazuya
authors.initials: K
authors.lastname: Yoshida
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Ohnishi
authors.forename: Reiji
authors.initials: R
authors.lastname: Haba
mesh_terms: D000368:Aged; D000740:Anemia / Q000628:therapy*; D001565:Benzoates / Q000008:administration & dosage*; D002908:Chronic Disease; D000077588:Deferasirox; D005260:Female; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage; D019190:Iron Overload / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D011859:Radiography; D013921:Thrombocytopenia / Q000628:therapy*; D065227:Transfusion Reaction; D014230:Triazoles / Q000008:administration & dosage*
chemical_list: D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox